A glance at some of the day’s highlights from the Proactive Investors US and Canada newswires
Esports Entertainment Group () shares climbed Thursday after an analyst from Noble Capital Markets raised the firm’s price target on the stock to $11 per share from $10 and reiterated an Outperform rating in a note to clients. “The company has recently closed on its EGL acquisition and appears set to soon close on Lucky Dino,” Noble wrote. “Based on comments at NobleCon 17, management appears sanguine about closing the ggCircuit and Helix acquisitions in March or early April. We believe that the closing of these acquisitions will raise the investment profile of the company.” Shares closed 7.1% higher Thursday at $8.27.
International Montoro Resources Inc () (OTCPINK:IMTFF) announced Thursday that its board of directors has approved the company’s name-change to Marvel Discovery Corp. The move is subject to the acceptance of the TSX Venture Exchange and the company will also be seeking the exchange’s approval to change its trading symbol to ‘MARV’ upon completion, according to a statement. While it awaits approval, the company said it will be doing all the necessary documentation associated with the name-change. The company added that the name-change will be done without any share consolidation.
Inc () (FRA:3AT) announced that it will launch a “wave of new digital initiatives” as part of its 2021 strategic growth plan, which includes investments in its technology infrastructure as well as the company’s digital platforms and products in order to achieve near-term profitability, debt reduction, and double-digit revenue growth. MediaCentral said it will build its foundational future on its alternative news platform NOW Magazine and the Georgia Straight, while the company’s new unified technology infrastructure is expected to significantly enhance the user experience across all of its wholly-owned digital platforms.
(NASDAQ: VUZI), a leading supplier of smart glasses and augmented reality (AR) technology and products, has completed the first phase of development with a US medical partner to build a customized head-mounted display system for assisted cancer surgery. The program was first announced in October 2020, New York-based Vuzix said in a statement. Vuzix said a second phase of development is currently being contemplated by the customer and could result in potentially greater non-recurring engineering (NRE) revenues, if awarded by the customer, in subsequent phases before an accepted final product design could be expected to lead to a volume original equipment manufacturing (OEM) production order.
()(FRA:1XMA)() announced Thursday that it closed a non-brokered private placement that raised $365,547. The offering consisted of 1,218,493 units at $0.30 apiece. Each Unit consists of one share and one transferable share…